Skip to main content
main-content

22-01-2018 | Image

Figure 3 : ADA induction after treatment with infliximab or CT-P13.

Comparative induction of ADAs against reference infliximab and CT-P13 in patients with ankylosing spondylitis (left) and rheumatoid arthritis (right) during two clinical studies (PLANETAS and PLANETRA, respectively).14,15,32 ADAs were assessed by electrochemical-luminescent immunoassay technology (Meso Scale Discovery). Abbreviation: ADA, antidrug antibody.

image credits